Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration

Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration

To evaluate the functional and anatomical effects of switching to faricimab for patients with neovascular age-related macular degeneration (nAMD) refractory to intravitreal aflibercept, this retrospective study evaluated patients with nAMD who received intravitreal injections of aflibercept (IVA) ev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical medicine 2023-08, Vol.12 (15), p.5145
Hauptverfasser: Kishi, Maya, Miki, Akiko, Kamimura, Aya, Okuda, Mina, Matsumiya, Wataru, Imai, Hisanori, Kusuhara, Sentaro, Nakamura, Makoto
Format: Artikel
Sprache:eng
Schlagworte:
Clinical medicine
Clinical outcomes
Clinical trials
Drug therapy
Macular degeneration
Medical imaging
Patient outcomes
Patients
Vascular endothelial growth factor
Visual acuity
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To evaluate the functional and anatomical effects of switching to faricimab for patients with neovascular age-related macular degeneration (nAMD) refractory to intravitreal aflibercept, this retrospective study evaluated patients with nAMD who received intravitreal injections of aflibercept (IVA) every
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm12155145